[1]
Khan, K. et al. 2024. Eosinophilic fasciitis as an immune-related adverse event of Pembrolizumab in Hodgkin’s lymphoma: a case report. KHYBER MEDICAL UNIVERSITY JOURNAL. 16, 2 (Jun. 2024), 171–4. DOI:https://doi.org/10.35845/kmuj.2024.23588.